A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia
ConclusionAirway obstruction is pharmacologically reversible in a number of patients with FD. In the short term, both albuterol and ipratropium were well tolerated and not associated with major cardiovascular adverse events.
Source: Lung - Category: Respiratory Medicine Source Type: research
More News: Albuterol | Cardiology | Cardiovascular | Clinical Trials | Heart | Proair HFA | Respiratory Medicine | Spirometry | Ventolin